( OTC-BB:NSPR )

News from InspireMD A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Sep 01, 2015, 08:00 ET InspireMD to Present at the Rodman & Renshaw 17th Annual Global Investment Conference

 InspireMD, Inc. (NYSE MKT: NSPR) a leader in stent embolic prevention systems ("EPS") and thrombus management technologies, today announced...


Aug 05, 2015, 16:10 ET InspireMD Reports Financial Results for the Second Quarter Ended June 30, 2015

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic prevention systems ("EPS"), today announced its...


Aug 05, 2015, 16:05 ET InspireMD Announces Distribution Partnership of its CGuard™ Embolic Prevention System with Penumbra, Inc.

InspireMD, Inc. (NYSE MKT: NSPR) a leader in stent embolic prevention systems ("EPS") and thrombus management technologies, today announced that it...


Jul 14, 2015, 08:00 ET InspireMD to Report Financial Results for the Second Quarter Ended June 30, 2015 on Wednesday, August 5th

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems, announced today that it will release...


Jul 07, 2015, 08:00 ET InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced that...


May 22, 2015, 08:00 ET InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced that...


May 12, 2015, 08:00 ET InspireMD Announces Clinical Presentations on CGuard and MGuard Systems with MicroNet™ Technology at EuroPCR 2015 Conference

InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced that there...


May 11, 2015, 08:00 ET InspireMD Reports Financial Results for the First Quarter Ended March 31, 2015

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced its...


May 05, 2015, 16:05 ET InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems, announced today that it will release...


Apr 27, 2015, 08:13 ET InspireMD Announces MGuard™ Prime Approval in Brazil

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced it...


Apr 15, 2015, 08:00 ET InspireMD Announces Completion of Sales Restructuring Program

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced the...


Mar 16, 2015, 09:00 ET InspireMD Plan of Compliance Accepted by NYSE MKT

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"),  announced today that...


Mar 12, 2015, 16:05 ET InspireMD Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2014

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced its...


Mar 09, 2015, 16:52 ET InspireMD Announces Closing of Public Offering for Approximately $13.7 Million

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems ("EPS"), today announced the...


Mar 06, 2015, 11:30 ET InspireMD to Report Financial Results for the Fourth Quarter and Year Ended December 31, 2014 on Thursday, March 12th

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems, announced today that it will...


Mar 04, 2015, 07:52 ET InspireMD Announces Public Offering for Approximately $13.5 Million

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems ("EPS"), today announced that...


Mar 03, 2015, 16:15 ET InspireMD Announces Proposed Public Offering of Common Stock and Warrants

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems ("EPS"), today announced that it...


Feb 26, 2015, 16:30 ET InspireMD to Present at the Cowen and Company 35th Annual Healthcare Conference

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced that its...


Jan 27, 2015, 08:30 ET InspireMD Receives CE Mark Approval for Its New CGuard RX and Announces Positive Six Month Follow-Up CARENET Trial Data at LINC 2015

InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced that it received...


Jan 21, 2015, 16:05 ET InspireMD Announces Notification of NYSE MKT Listing Deficiency

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced the receipt...


Jan 13, 2015, 08:30 ET InspireMD to Announce Positive Six Month Results from the CGuardTM CARENET Trial at LINC 2015

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced that six...


Jan 05, 2015, 16:30 ET InspireMD Pre-Announces a Fourth Quarter 2014 Revenue Increase of 200% Over the Third Quarter of 2014 and Provides Update on Corporate and Commercial Strategies

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today...


Dec 15, 2014, 08:30 ET InspireMD Announces Important Clinical Data from MASTER and CARENET Trials

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced results from...


Nov 12, 2014, 16:11 ET InspireMD Reports Financial Results for the Third Quarter ended September 30, 2014

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced its...


Nov 07, 2014, 17:20 ET InspireMD Completes $8.1 Million Registered Direct Offering

InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in stent Embolic Protection Systems (EPS), today announced the...